Trial Profile
Efficacy of infliximab biosimilar in patients with moderate to severe plaque psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Oct 2016 New trial record